ABBV has been in the news 409% more than usual
Mar 11, 2026, 6:31 AM
-7.97%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie Inc. (NYSE: ABBV) experienced a decline in its stock performance on Monday, despite reporting record revenues of $61.2 billion in 2025 after losing the patent for Humira. Additionally, AVK and Pure Data Centre Group launched Europe's first data center powered by a live microgrid in Dublin to tackle energy supply issues related to increasing AI demands.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.